All lobbying filings

EAST END GROUP, LLC

EAST END GROUP, LLC filed a Q2 amendment for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA on July 15, 2026, reporting $75,000 in lobbying income.

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Trade association for the pharmaceutical product discovery and development industry.

All filings by EAST END GROUP, LLC · Everything PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA has reported

Filing · LD-2 quarterly report Q2 amendment

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 15, 2026

Income

$75,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.